CollPlant Biotechnologies CLGN
NASDAQ CLGN
$0.31 +0.01 (+4.06%)
As of: Aug 21, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Return on Assets Growth (1y) (2019 - 2025)

CollPlant Biotechnologies (CLGN) Return on Assets Growth (1y) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CollPlant Biotechnologies 4.26 Mn 4.26 Mn -243,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.00
Sep 30, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 1.00
Jun 30, 2024 0.00
Mar 31, 2024 1.00
Dec 31, 2023 1.00
Sep 30, 2023 4.00
Jun 30, 2023 3.00
Mar 31, 2023 2.00
Dec 31, 2022 2.00
Sep 30, 2022 -7.00
Jun 30, 2022 -4.00
Mar 31, 2022 -6.00
Dec 31, 2021 -4.00
Sep 30, 2021 0.00
Jun 30, 2021 -1.00
Mar 31, 2021 2.00
Dec 31, 2020 -1.00
Sep 30, 2020 2.00